Our findings suggested that PINK1/Parkin/Ubiquitin mechanism may be involved in berberine mediated cardioprotective effects on TAC-induced adverse cardiac hypertrophy, and even on chronic HF. Here, PINK1 is linked to cardiac hypertrophy.